|Bid||61.86 x 800|
|Ask||120.00 x 1000|
|Day's Range||61.86 - 64.60|
|52 Week Range||53.95 - 80.00|
|Beta (5Y Monthly)||1.04|
|PE Ratio (TTM)||82.25|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 10, 2018|
|1y Target Est||N/A|
It is hard to get excited after looking at Taro Pharmaceutical Industries' (NYSE:TARO) recent performance, when its...
Taro (TARO) delivered earnings and revenue surprises of 29.76% and 7.23%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Taro Pharmaceutical Industries (TARO) has been struggling lately, but the selling pressure may be coming to an end soon.